Fexofenadine hydrochloride

(Redirected from Fexofenadine)
Jump to: navigation, search
Fexofenadine hydrochloride
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Fexofenadine hydrochloride is an antihistamine that is FDA approved for the treatment of runny nose,itchy watery eyes, sneezing, itching of the nose or throat. Common adverse reactions include stomach ache, backache, dizziness , headache , somnolence,fatigue, pain in limb.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications

Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

Dosing

This image is provided by the National Library of Medicine.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Fexofenadine in adult patients.

Non–Guideline-Supported Use

Indications

  • Hymenoptera immunotherapy, pretreatment[1]

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Indications

Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

Dosing

This image is provided by the National Library of Medicine.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Fexofenadine in pediatric patients.

Non–Guideline-Supported Use

Indications

Contraindications

There is limited information regarding Fexofenadine hydrochloride Contraindications in the drug label.

Warnings

Do not use

  • If you have ever had an allergic reaction to this product or any of its ingredients.

Ask a doctor before use if you have

  • Kidney disease. Your doctor should determine if you need a different dose.

When using this product

  • Do not take more than directed
  • Do not take at the same time as aluminum or magnesium antacids
  • Do not take with fruit juices (see Directions)

Stop use and ask a doctor if

  • An allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding

Ask a health professional before use.

Keep out of reach of children

  • In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Fexofenadine

Postmarketing Experience

Common

Drug Interactions

There is limited information regarding Fexofenadine hydrochloride Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Fexofenadine hydrochloride in women who are pregnant.
Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of fexofenadine hydrochloride in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of fexofenadine hydrochloride during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of fexofenadine hydrochloride with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of fexofenadine hydrochloride with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of fexofenadine hydrochloridewith respect to geriatric patients.

Gender

There is no FDA guidance on the use of fexofenadine hydrochloride with respect to specific gender populations.

Race

There is no FDA guidance on the use of fexofenadine hydrochloride with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of fexofenadine hydrochloride in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of fexofenadine hydrochloride in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of fexofenadine hydrochloride in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance on the use of fexofenadine hydrochloride in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Oral

Monitoring

There is limited information regarding Monitoring of fexofenadine hydrochloride in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of fexofenadine hydrochloride in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of fexofenadine hydrochloride in the drug label.

Pharmacology

There is limited information regarding Fexofenadine hydrochloride Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding mechanism of action: of fexofenadine hydrochloride in the drug label.

Structure

There is limited information regarding structure: : of fexofenadine hydrochloride in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of fexofenadine hydrochloride in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of fexofenadine hydrochloride in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of fexofenadine hydrochloride in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of fexofenadine hydrochloride in the drug label.

How Supplied

There is limited information regarding Fexofenadine hydrochloride How Supplied in the drug label.

Storage

There is limited information regarding Fexofenadine hydrochloride Storage in the drug label.

Images

Drug Images

Package and Label Display Panel

Fexofenadine ingredients and appearance.png
This image of the FDA label is provided by the National Library of Medicine.
Fexofenadine fig01.jpg
This image of the FDA label is provided by the National Library of Medicine.

Patient Counseling Information

There is limited information regarding Patient Counseling Information of fexofenadine hydrochloride in the drug label.

Precautions with Alcohol

  • Alcohol- fexofenadine hydrochloride interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

7 SELECT ALLERGY RELIEF

Look-Alike Drug Names

There is limited information regarding Fexofenadine hydrochloride Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. 1.0 1.1 Reimers A, Hari Y, Müller U (2000). "Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial". Allergy. 55 (5): 484–8. PMID 10843430 PMID: 10843430 Check |pmid= value (help).
  2. 2.0 2.1 Bunnag C, Jareoncharsri P, Tunsuriyawong P, Pumhirun P, Limprasertsiri S, Chochaipanichnon L; et al. (2000). "A non-comparative trial of the efficacy and safety of fexofenadine for treatment of perennial allergic rhinitis". Asian Pac J Allergy Immunol. 18 (3): 127–33. PMID 11270466 PMID: 11270466 Check |pmid= value (help).